ALEXZA PHARMACEUTICALS INC's ticker is ALXA and the CUSIP is 015384209. A total of 43 filers reported holding ALEXZA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.12 and the average weighting 2.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $294,000 | -63.9% | 126,095 | -29.2% | 0.14% | -63.3% |
Q2 2014 | $814,000 | +29.4% | 178,195 | +25.4% | 0.38% | +17.1% |
Q1 2014 | $629,000 | -6.5% | 142,060 | -0.1% | 0.32% | -6.4% |
Q4 2013 | $673,000 | -9.5% | 142,180 | -2.1% | 0.34% | -11.8% |
Q3 2013 | $744,000 | – | 145,283 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LANSDOWNE PARTNERS AUSTRIA GMBH | 1,355,255 | $6,410,000 | 100.00% |
FORTALEZA ASSET MANAGEMENT INC/ | 142,180 | $673,000 | 0.34% |
Lombard Odier & Cie (Bahamas) Ltd | 44,000 | $208,000 | 0.08% |
HOWARD HUGHES MEDICAL INSTITUTE | 98,914 | $468,000 | 0.07% |
KENNEDY CAPITAL MANAGEMENT LLC | 476,645 | $2,255,000 | 0.04% |
BBT Capital Management, LLC | 118,033 | $558,000 | 0.02% |
ROCKY MOUNTAIN ADVISERS, LLC | 350 | $2,000 | 0.02% |
Jefferies Group LLC | 520,400 | $2,461,000 | 0.02% |
Granite Point Capital Management, L.P. | 16,574 | $78,000 | 0.01% |
Compagnie Lombard Odier SCmA | 55,000 | $260,000 | 0.01% |